Archives March 2026

Business Wire India

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that its specialized aesthetic brand, “NEO Skin Clinic,” will open its flagship location in Tokyo’s Ginza district, a globally recognized medical tourism hub and highly competitive district, on Saturday, March 28, 2026.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312457783/en/

 

 

 

The Ginza flagship, located in a prime area near GINZA SIX, will feature dedicated VIP rooms for executive clientele and the growing number of international patients, strengthening the brand’s global presence. Leveraging its robust network of 283 affiliated clinics (as of December 2025) and extensive clinical data, SBC Medical continues to advance its multi-branding strategy to meet evolving market needs.

 

Following the successful validation of the business model at the Ebisu clinic launched in April 2025, the new flagship in Ginza is expected to further diversify the Group’s revenue base and improve profitability through a high-value-added service model.

 

 

The aesthetic healthcare sector is undergoing rapid evolution, driven by the continuous development of new treatment devices and formulations, which is increasing consumer awareness and demand. Modern patients are increasingly seeking the latest technology, applying the same level of discernment to high-end cosmetics. To address these market dynamics, NEO Skin Clinic leverages the Company’s extensive global network and strong relationships with medical device manufacturers to maintain a premier lineup of treatments that are regularly updated. The brand offers a sustainable, accessible pricing structure aligned with international standards, including those in South Korea, to meet rising patient expectations for both quality and value.

 

 

Beyond advanced technology, NEO Skin Clinic emphasizes a proprietary treatment approach that combines scientific precision with objective data from the VISIA skin diagnostic system. To ensure technical excellence, the brand has appointed Dr. Nariaki Miyata, a leading authority on aesthetic dermatology in Japan, and Dr. Youn Seongjae, Representative Director of Leaders Dermatology Clinic in South Korea, as technical advisors. By integrating advanced clinical insights from both Japan and South Korea, SBC Medical has established a world-class training system for its physicians and staff.

 

 

As global interest in non-invasive treatments and quality of life continues to grow, SBC Medical remains committed to maintaining its domestic dominance and pursuing international expansion.

 

 

The Company plans to further expand its footprint into the Nagoya and Kobe areas by the end of 2026, aiming for sustainable growth and long-term enhancement of corporate value.

 

 

Message from Soichiro Morikawa, M.D., Director

 

 

I believe that the essence of aesthetic healthcare lies not merely in the ‘procedure’ itself, but in the precision of ‘diagnosis’ and ‘treatment’ that dictates the final outcome. Every customer is unique—skin condition, fat distribution, muscle movement, and the progression of aging vary from person to person. At NEO Skin Clinic Ginza, I place the highest priority on designing treatment strategies based on rigorous medical evidence, taking into account both the customer’s current state and future physiological changes. Whether using injectable therapies or advanced energy-based devices, achieving natural and sustainable results requires a deep understanding of each modality’s characteristics, applied at the optimal timing and in the right combination. My commitment is to provide aesthetic dermatology that moves beyond subjective intuition, focusing instead on evidence-based care to ensure long-term beauty and facial harmony.

 

 

Clinic Overview

 

 

Business Hours: 10:00 AM – 7:00 PM
Regularly Closed: Mondays and Thursdays
Location: 3F, Hulic Ginza Wall Building, 6-13-16 Ginza, Chuo-ku, Tokyo 104-0061, Japan
Access:
2-minute walk from Exit A1 of Higashi-ginza Station (Tokyo Metro Hibiya Line)
3-minute walk from Exit A5 of Ginza Station (Tokyo Metro Ginza and Hibiya Lines)
Phone: 0120-217-498 (Toll-free within Japan)
Official Website: https://www.sbc-neoskinclinic.jp/

 

 

About SBC Medical Group Holdings Incorporated

 

 

SBC Medical Group Holdings Incorporated is a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

 

 

For more information, visit https://sbc-holdings.com

 

 

For more insights and updates from SBC Holdings, follow us on LinkedIn.

 

 

Forward-Looking Statements

 

 

This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260312457783/en/

 

Business Wire India

GCE®, a global market leader for gas control equipment, has launched gascontrol.com, a new website designed to better serve customers across its GCE Specialty, GCE Medical, and GCE Industrial product portfolios. The new site provides a streamlined, market-focused experience that makes it easier for users to explore GCE’s gas control solutions and identify the right products. A new Documentation Search Tool assists customers in easily finding documents such as instructions for use (IFUs), appendices, and certifications through an intuitive search interface.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316410525/en/

 

 

 

“The redesigned website reflects GCE’s role as a comprehensive, trusted supplier of gas control technologies that elevate industries and improve lives,” says Piyush Sheth, Vice President and General Manager, GCE. “With improved navigation, content organized by application and industry, and a list of global contacts, the site is intended to support engineers, clinicians, system designers, distributors, and procurement teams throughout the decision-making process.”

 

Three Product Groups

 

 

Backed by ESAB Corporation (NYSE: ESAB), GCE has grown its global footprint through the merging of leading gas-equipment providers, expanding its reach across the Americas, Asia, and Europe. Its products undergo rigorous testing and certifications to meet international quality and safety standards. GCE is organized into three product divisions:

 

 

GCE Speciality (gce-speciality.com) — incorporating the druva^®, GASARC^® and Victor^®, brands — caters to high-purity market sectors such as pharmaceutical, semiconductor and automotive manufacturing, analytical laboratories, food and beverage, refrigeration, and industrial applications. GCE engineers regulators, manifolds, and other specialized products to maintain gas purity and deliver consistent, repeatable performance in environments where even minor contamination or pressure variation can impact results. GCE’s FloCloud digital solution enables users to monitor gas levels, detect gas leaks and confirm system integrity, monitor consumption, identify over-consumption, ensure gas flow and pressure are within limits for consistent quality, and allocate costs.

 

 

GCE Medical (gce-medical.com) — incorporating GCE Healthcare, Therapy Equipment, Ohio Medical, DeltaP and Aktiv Technologies brands — serves pre-hospital, hospital, emergency, and home care medical settings. Products include medical source gas equipment, medical high-pressure regulators, gas manifolds and pipeline systems, oxygen concentrators, ambulance panels, emergency equipment, and other products that ensure the safe and reliable delivery of life-supporting gases from source to patient.

 

 

GCE Industrial (gce-industrial.com) — incorporating the Kayser brand — has its origins in oxy fuel welding and cutting and has expanded into segments that use regulators, valves, central gas supply systems, cutting and welding torches and equipment, welding consumables, and safety gear. In industrial applications, the FloCloud Industry 4.0 gas monitoring solution reduces the costs and chance of error that comes from manually checking gas levels, reduces the cost of waste associated with parameters being out of specification, and reduces the chance of interrupted flow, and helps detect leaks.

 

 

About GCE

 

 

GCE Group, part of ESAB Corporation (NYSE: ESAB), is a leading global manufacturer of gas control equipment. Driven by innovation across our brands, including Ohio® Medical and Therapy Equipment, we strive to deliver the highest quality gas control products and services. Our portfolio offers market compliant, industry leading solutions for the medical, industrial and specialty gas industries. With international manufacturing, sales, and supply, we ensure customers can always access the world’s leading innovative gas control equipment. To learn more, visit https://www.gascontrol.com/en/about-us

 

 

PR-23132

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316410525/en/

 

The University of Birmingham is one of the UK’s largest universities with almost 30,000 students in attendance. As with many established universities, it faced the challenge of how to modernise its diverse estate to meet the contemporary learning-styles that have arisen in recent years. Student expectations around audiovisual technology have changed and the University of Birmingham’s LRAT / Libraries and Learning Resources in-house AV team worked with GVAV, its longstanding integration partner, to upgrade dated equipment over the Summer of 2025.  

Conceived as a campus-wide initiative to be carried out over the long-term, the university team initially sought to upgrade several key learning spaces which could quickly benefit from moving beyond the constraints of legacy equipment to create truly flexible, high-impact environments for both students and lecturers. 

“Some of our older rooms were saddled with dim, non-interactive projection systems and related connectivity issues,” says James Ball, LRAT – AV Designer and Project Lead. Lecturers had become reluctant to use the technology, and students could find the group-work experience frustrating. Our goal was simple: to improve the visual and learning experience for all. A big help in this respect was our use of a broad range of Avocor displays.”  

Avocor was deployed across several distinct teaching environments, each with a specific learning goal and technology configuration. SportEx LT1 is one of the university’s flagship lecture theatres and is used for large-scale lecturing, sports performance and biometric analysis. It also has the potential to be a revenue-generator once it is made available for commercial hire. However, the room suffered from a legacy Issue: it relied on a dual projection setup, which on occasions resulted in an image that was difficult to view clearly from the back rows of the large lecture theatre. To address this issue, as part of the AV upgrade, the room was fitted with an Avocor X Series DVLED display. 

The X Series was chosen specifically over a standard projector wall or LCD videowall for its superior brightness and contrast. This ensures content can be viewed effortlessly and clearly by every person in the room, even those seated at the very back. The high-resolution, high-contrast wall serves as a central focal point, displaying content with unparalleled visual clarity – for sports analysis work, clarity and zero latency are non-negotiable. The Avocor DVLED provided the brightness and the visual scale that simply couldn’t be achieved with a standard projection system, making it a truly immersive experience for our students. 

Opting for the X Series also provided a significant logistical advantage during the installation. Projection is notoriously expensive and time-consuming to install due to the requirement for specialist scaffolding. The X Series install was much quicker, delivered to site by Avocor, streamlining the process for GVAV. To maximise adoption, the system was designed for simplicity, and the control panel layouts are intuitively designed, ensuring lecturers can operate the powerful new system with minimal training. 

The project also completely redesigned key spaces Muirhead 112 (featuring 8 x 55″ K-Series displays) and Y3 G28 (with 5 x 55″ K-Series displays) to move away from traditional lecture-style seating. These rooms were re-envisioned as highly flexible “collaboration pods,” specifically tailored to facilitate and enhance small-group active learning. Students can connect their personal devices—laptops or tablets—to the Avocor K-Series 55″ displays enabling immediate collaboration. The system also provides the lecturer with effortless monitoring and control over all screens. This capability allows them to quickly share a central content source to all pods simultaneously. The K-Series was selected for its blend of performance and form factor to enable seamless group collaboration. 

In further teaching environments, Muirhead 109 and 118, the team implemented a dual-display configuration to support the dynamic requirements of hybrid teaching. A large 98″ K-Series display is expertly paired with a second, smaller 65″ K-Series screen. This setup dedicates the primary 98″ screen to displaying core teaching content, such as slides, digital whiteboards, or lecture materials. The secondary 65″ screen can mirror the content on the 98” screen or can be used independently for group work.  

The University of Birmingham’s campus-wide AV transformation stands as a testament to what can be achieved when an integrator partner like GVAV works in close partnership with the client team (LRAT), truly understanding their needs and aspirations. By leveraging Avocor’s versatile range of high-quality display solutions, each tailored to the unique requirements of specific learning environments, the project has delivered flexible, impactful spaces that empower both students and lecturers. This collaborative approach ensured every installation was not only technically robust but also aligned with the university’s vision for modern, engaging education. The result is a series of innovative learning spaces that exemplify best practice in AV integration, demonstrating that with the right partnership and technology, ambitious goals can be realized and lasting success achieved. 

Business Wire India

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & R&D Consulting Services, has announced its next-generation, AI-powered digital twin platform for lung navigation, surgical planning and respiratory diagnostics.

 

The platform combines LTTS’ industry-leading MedTech expertise across medical imaging, AI-driven diagnostics, and connected healthcare systems with NVIDIA AI infrastructure to enable greater precision and enhanced outcomes.

 

LTTS’ lung digital twin solution integrates directly with CT imaging workflows and leverages deep learning models to reconstruct a comprehensive 3D digital twin of the lungs. This redefines visualization of critical anatomical structures including airways, blood vessels, lung lobes, and lesions, enabling clinicians to explore patient-specific lung anatomy in an immersive digital environment and simulate procedural pathways for bronchoscopy and biopsy planning.

 

The platform is powered by NVIDIA Physical AI infrastructure, including:

 

• NVIDIA Omniverse and OpenUSD for interactive 3D digital twin visualization of lung anatomy and supporting immersive exploration of complex structures,
• NVIDIA TensorRT to drive optimized AI inference performance across high-speed clinical workflows, and
• NVIDIA MONAI to enable advanced medical image segmentation, enabling automated identification of airways, vessels, tumors and lung lobes.

 

LTTS’ scalable digital twin platform transforms static CT scans into dynamic, simulation-ready lung models, allowing clinicians to analyze anatomical relationships, plan surgical pathways and navigate bronchoscopic procedures with enhanced accuracy. The framework also supports advanced visualization, automated segmentation, volumetric analysis, and navigation path planning, helping clinicians reduce pre-operative planning time and improve overall procedural safety.

 

“By combining LTTS’ engineering expertise in medical imaging and digital health platforms with the power of NVIDIA’s Physical AI infrastructure, we are enabling a new generation of AI-powered biological digital twins for precision medicine,” observed Amit Chadha, CEO & Managing Director, L&T Technology Services. “These platforms can transform how clinicians visualize lung anatomy, plan interventions and deliver precision care. The impact will be visible across the global healthcare ecosystem in the years ahead.”

 

David Niewolny, Head of Business Development for Healthcare and Medical Technology, NVIDIA, said, “Digital twins are emerging as a powerful new tool for precision medicine. By leveraging NVIDIA Physical AI infrastructure, Omniverse, MONAI and TensorRT, LTTS is transforming CT data into interactive lung digital twins that allow clinicians to visualize anatomy in 3D, simulate procedures and plan clinical interventions with greater confidence.”

 

With respiratory diseases such as lung cancer and COPD continuing to rise globally, AI-driven digital twin technologies are expected to accelerate the shift from traditional imaging interpretation toward predictive, simulation-driven and minimally invasive intervention planning, enabling more personalized and data-driven treatment pathways.

Business Wire India

Experian today unveiled the next evolution of the Experian Virtual Assistant, EVA™, a significant advancement in its Consumer First AI strategy that expands personalized, conversational financial guidance to millions of consumers.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316538160/en/

 

 

“This next generation of EVA reflects the direction of our consumer AI strategy,” said Debbie Hsu, Executive Vice President of Product, Experian Consumer Services. “We are bringing together conversational AI, personalization, and our trusted data foundation to deliver guidance that is intuitive, relevant, and actionable. Our focus is on helping consumers make smarter financial decisions in ways that feel simple and empowering.”

 

Built to scale intelligent financial guidance through a more adaptive experience, the enhanced EVA expands beyond credit insights to provide near real-time spending analysis, tailored recommendations, and relevant financial offers based on available account data. Powered by Experian’s proprietary data, consumer-permissioned information, and advanced artificial intelligence capabilities, EVA is available to deliver intelligent financial support to more than 85 million members.

 

This evolution reflects Experian’s broader commitment to embedding adaptive AI across the consumer journey and transforming how people engage with their financial information.

 

A Financial Copilot for Everyday Decisions*

 

Since launch, EVA has helped consumers better understand their credit through secure, real-time conversations. With this latest evolution, members gain visibility into how everyday spending affects their overall financial picture through insights from connected financial accounts.

 

Spending trends over time can be tracked, top categories and largest transactions identified, and opportunities to reduce unnecessary expenses uncovered. Members may also explore personalized credit card offers from third-party lenders available through Experian Marketplace within a seamless, guided experience.

 

By translating complex financial data into clear, practical next steps, EVA serves as an intelligent financial copilot, helping consumers move from insight to action with confidence.

 

For example, instead of only displaying a FICO® Scoreⁱ, EVA can analyze a member’s connected accounts and highlight recent spending patterns, such as increased dining or subscription costs compared to prior months. The assistant can identify top spending categories, flag larger transactions, and help members manage upcoming bills and subscriptions by surfacing expected due dates, predicted amounts, and total monthly recurring spending.

 

In simple terms, EVA helps members clearly see where their money is going in near real time and understand how everyday spending fits into their overall financial picture — all within a seamless, conversational experience.

 

Intelligent, Adaptive and Built on Trusted Data

 

Interactions with EVA evolve in real time based on how each member engages. The assistant tailors explanations, surfaces relevant insights, and prioritizes recommendations aligned with an individual’s credit and financial goals. Experian designs and monitors its AI systems using established governance, testing, and oversight frameworks to promote fairness, transparency, and consumer protection.

 

Grounded in Experian’s credit expertise, data, and consumer permissioned financial information, EVA delivers personalized guidance designed with privacy and security as core principles. The experience supports consumers as they navigate important financial decisions with greater clarity and confidence.

 

Whether someone is new to credit, managing monthly expenses, or exploring new financial opportunities, EVA translates complexity into clarity and action.

 

“By combining advanced AI with consumer first design and a foundation of trusted data, we are expanding access to personalized financial tools and creating more opportunities for financial inclusion,” Hsu added.

 

Consumer First AI in Action

 

This milestone builds on Experian’s broader strategy to embed intelligent, trusted AI across the consumer ecosystem. Through advancements in EVA’s adaptive financial guidance and the launch of Experian Insurance Marketplace app integrated with the ChatGPT platform, Experian continues meeting consumers wherever they are with personalized insights and relevant financial opportunities delivered through conversational experiences.

 

Collectively, these innovations reflect Experian’s long-term vision to combine proprietary data, advanced AI, and the trust of a Big Financial Friend (BFF) to enable more intuitive financial decision-making in the moments that matter most to consumers.

 

EVA is available to Experian members through the Experian mobile app and website. To learn more or enroll, visit www.experian.com.

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realize their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

*EVA provides general information and educational insights only. It is not a financial advisor and does not provide personalized investment, legal, tax, or accounting advice, nor does it establish any advisor-client or fiduciary relationship. Any financial offers displayed are provided by third-party lenders and are subject to the lenders’ eligibility and approval processes. Users should consult a qualified, licensed professional for personalized advice. Experian’s AI tools operate under internal governance, testing, and privacy controls designed to promote accuracy, fairness, and consumer protection.

 

Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.

 

ChatGPT is a trademark of OpenAI. The Experian Insurance Marketplace app is developed and operated by Experian and is not affiliated with or endorsed by OpenAI.

 

____________________

i Credit score calculated based on FICO® Score 8 model. Your lender or insurer may use a different FICO® Score than FICO® Score 8, or another type of credit score altogether. Learn more.

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260316538160/en/